14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CORZZ vs CPAY: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Corpay, Inc. (CPAY) is the stronger overall head-to-head candidate over Core Scientific, Inc. Tranche 2 Warrants (CORZZ) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CORZZ carries a Unified Composite Score of 34.3/100 (SELL) at $13.44 (N/M Forward P/E, N/A operating margin), whereas CPAY carries 32.0/100 (SELL) at $460.70 (14.5x Forward P/E, 49.8% operating margin).
Composite vs. Pillar Nuance: While CORZZ currently prints a higher short-term Unified Composite Score (34.3/100 SELL vs. CPAY 32.0/100 SELL), CPAY captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (49.8% vs. N/A operating margin) and revenue trajectory (+17.9% vs. N/A YoY).
Defensive Composite Rating Caution: Although CPAY compares more favorably head-to-head, both CORZZ (34.3/100 SELL) and CPAY (32.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CORZZ vs CPAY. Trailing 12-month operating profitability (CORZZ N/A vs CPAY 49.8%) and valuation multiples (CORZZ N/M vs CPAY 14.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Finance Services value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
CPAY Moat ProfileHigh-Margin Pricing Power Moat
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $29.2B market capitalization and 49.8% operating margin.
OpEx & R&D Reinvestment31.0% of Rev ($1.62B)
90D Engineering Disclosures0 Published
Investor FAQ CORZZ vs CPAY Key Questions & Quantitative Answers
As of Nov 16, 2026, Corpay, Inc. (CPAY) is the stronger overall head-to-head candidate over Core Scientific, Inc. Tranche 2 Warrants (CORZZ) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CORZZ carries a Unified Composite Score of 34.3/100 (SELL) at $13.44 (N/M Forward P/E, N/A operating margin), whereas CPAY carries 32.0/100 (SELL) at $460.70 (14.5x Forward P/E, 49.8% operating margin). Composite vs. Pillar Nuance: While CORZZ currently prints a higher short-term Unified Composite Score (34.3/100 SELL vs. CPAY 32.0/100 SELL), CPAY captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (49.8% vs. N/A operating margin) and revenue trajectory (+17.9% vs. N/A YoY). Defensive Composite Rating Caution: Although CPAY compares more favorably head-to-head, both CORZZ (34.3/100 SELL) and CPAY (32.0/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
CPAY leads the Growth & Scale pillar: CORZZ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CPAY at +17.9% YoY revenue growth and +44.8% YoY earnings growth on $5.23B TTM revenue (80.8% gross margin, 49.8% operating margin). On trailing 12-month operating scale, CORZZ generates N/A in USD-normalized revenue versus $5.23B for CPAY. In operating R&D and SG&A reinvestment, CORZZ deploys N/A (0 90-day corporate R&D disclosures) versus 31.0% of Rev ($1.62B) (0 disclosures) for CPAY.
CPAY screens cheaper on headline valuation multiples. CORZZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CPAY trades at 14.5x Forward P/E, 25.1x Trailing P/E, 0.88x PEG, and 7.1x EV/Revenue (25.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CORZZ (N/A ROE) versus CPAY (32.2% ROE) capital efficiency.
In options market volatility and institutional positioning, CORZZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.88β · 102% Vol realized risk). By comparison, CPAY carries 24.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 2.33x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.26β · 30% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.